Filing Details
- Accession Number:
- 0000902664-21-003604
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-21 16:36:58
- Reporting Period:
- 2021-07-19
- Accepted Time:
- 2021-07-21 16:36:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1531177 | Sight Sciences Inc. | SGHT | Surgical & Medical Instruments & Apparatus (3841) | 800625749 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1621588 | S. Daniel Sundheim | C/O D1 Capital Partners L.p. 9 West 57Th Street, 36Th Floor New York NY 10019 | No | No | Yes | No | |
1747057 | L.p. Partners Capital D1 | 9 West 57Th Street 36Th Floor New York NY 10019 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value Per Share ("Common Stock") | Acquisiton | 2021-07-19 | 5,152,036 | $0.00 | 5,152,036 | No | 4 | C | Indirect | See footnote |
Common Stock | Acquisiton | 2021-07-19 | 700,000 | $24.00 | 5,852,036 | No | 4 | P | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series E Convertible Preferred Stock | Disposition | 2021-07-19 | 1,890,395 | $0.00 | 3,780,790 | $0.00 |
Common Stock | Series F Convertible Preferred Stock | Disposition | 2021-07-19 | 685,623 | $0.00 | 1,371,246 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock was convertible at any time, at the holder's election, into shares of the Issuer's Common Stock on a 2-for-1 basis. The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 2-for-1 basis upon the closing of the Issuer's initial public offering. The Series E Convertible Preferred Stock and the Series F Convertible Preferred Stock did not have an expiration date.
- This statement is filed by D1 Capital Partners L.P. (the "Investment Manager") and Daniel Sundheim ("Mr. Sundheim"). The foregoing persons are hereinafter sometimes referred to as the "Reporting Persons." The Investment Manager is a registered investment adviser and serves as the investment manager of private investment vehicles and accounts, including D1 Capital Partners Master LP (the "Investment Vehicle"). Mr. Sundheim may be deemed to beneficially own the reported securities by virtue of the fact that Mr. Sundheim indirectly controls the Investment Manager. The filing of this statement should not be construed as an admission that any Reporting Person is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of the securities reported except to the extent of its pecuniary interest therein.